Doxycycline Hyclate for Injection, 100mg

Tender details

The Canadian Forces Health Services Group requires the supply of 15,120 units of injectable Doxycycline Hyclate 100mg for treating CAF members potentially exposed to bacterial biological warfare agents. Delivery is needed by 31 March 2026, with an option for an additional 60,480 units over the contract's duration. The contract will run from award until 31 March 2030, and the product must be in lyophilized powder form for reconstitution.